Best Management of Muscle Relaxation- Objective Monitoring

NCT03958201 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Residual Paralysis, Post Anesthesia

Interventions

COMBINATION_PRODUCT: Protocol for Management of Muscle Relaxation With Rocuronium Using Objective Monitoring and Reversal With Neostigmine or Sugammadex

Sponsor

University of Washington